参考文献
[1]Jun Lan,Jiwan Ge,Jinfang Yu,et al.Structure of the SARS-CoV-2 spike receptorbinding domain bound to the ACE2 receptor[J].Nature,2020,581:215-220.
[2]Peter Forster,Lucy Forster,Colin Renfrew,et al.Phylogenetic network analysis of SARS-CoV-2 genomes[J].PNAs,2020,117(17): 9241-9243.
[3]Miao Gui,Wenfei Song,Haixia Zhou,et al.Cryo-electron microscopy structures of the SARS-CoV spike glycoprotein reveal a prerequisite conformational state for receptor binding[J].Cell Res,2017(27):119-148.
[4]Yuan Yuan,Duanfang Cao,Yanfang Zhang,et al.Cryo-EM structures of MERSCoV and SARS-CoV spike glycoproteins reveal the dynamic receptor binding domains[J].Nat Commun,2017 (8): 15902-15011.
[5]朱端昊,冯长华,路亮,等.人类免疫缺陷病毒HIV-1基因分型方法的初步构建,病毒监测,2015,30(9):789-791.
[6]Gelderblom H R,Ozel M,Pauli G.Morphogenesis and morphology of HIV.Structure-function relations[J].Arch Virol,1989(106): 1-13.
[7]Whittle H,Morris J,Todd J,et al.HIV-2-infected patients survive longer than HIV-1-infected patients[J].AIDS,1994(8): 1617-1637.
[8]Miceli M C,Pames J.Role of CD4 and CD8 in T cell activation and diあerentiation[J].Adv Immunol,1993(53): 59-122.
[9]Lucas S,Hounou A,Peacock C,et al.The mortality and pathology of HIV infection in a West African city[J].AIDS,1993(7): 1569-1579.
[10]Geisbert T W,Jahrling P B.Diあerentiation of filoviruses by electron microscopy[J].Virus Res,1995(39): 129-150.
[11]Julia Schlereth,Arnold Grünweller,Nadine Biedenkopf,et al.RNA binding specificity of Ebola virus transcription factor VP30[J].RNA Biol,2016,13(9): 783-798.
[12]孙英尧,董浩.埃博拉病毒分子生物学研究进展[J].中国兽药杂志,2019,53(4):77-80.
[13]Fenner F.Adventures with poxviruses of vertebrates[J].FEMS Microbiol Rev,2000,24(2): 123-133.
[14]Moore Z S,Seward J F,Lane J M.Smallpox[J].Lancet,2006(367): 425-435.
[15]Roth J R,Andersson D I.Poxvirus use a “gene accordion” to tune out host defenses[J].Cell,2012(150): 671-672.
[16]Esposito J J,Sammons S A,Frace A M,et al.Genome sequence diversity and clues to the evolution of variola smallpox virus[J].Science,2006(313): 807-812.
[17]Thomson G R,Gainaru M D,van Dellen A F.Experimental infection of warthos(Phacochoerus aethiopicus) with african swine fever virus[J].Onderstepoort J Vet Res,1980,47(1): 19-22.
[18]Kleioeker S B,Scoles G A,Burrage T G,et al.African swine fever virus replication in the midgut epithelium is required for infection of ornithodoros ticks[J].Virol,1999(73): 8587-8598.
[19]Grzegorz Woźniakowski,Edyta Kozak,Andrzej Kowalczyk,et al.Current status of african swine fever virus in a population of wild boar in eastern Poland (2014-2015)[J].Arch Virol,2016(161): 189-195.
[20]Boshoあ C I,Bastos A D,Gerber,et al.Genetic characterisation of african swine fever viruses from outbreaks in southern Africa (1973-1999)[J].Vet Microbiol,2007(121): 45-55.
[21]Bastos A D,Penrith M L,Crucière C,et al.Genotyping field strains of african swine fever virus by partial p72 gene characterisation[J].Arch Virol,2003(148):693-706.
[22]García-Beato R,Salas M L,Viuela E,et al.Role of the host cell nucleus in the replication of African swine fever virus DNA[J].Virology,1992,188(2):637-649.
[23]María L Salas,Germán Andrés.African swine fever virus morphogenesis[J].Virus Res,2013(173): 29-41.
[24]Schloer G M.Polypeptides and structure of African swine fever virus[J].Virus Res,1985(3): 295-310.
[25]Riley L W,Remis R S,Helgerson S D,et al.Hemorrhagic colitis associated with a rare Escherichia coli serotype[J].N Engl J Med,1983,308(12): 681-685.
[26]Wells J G,Davis B R,Wachsmuth I K,et al.Laboratory investigation of hemorrhagic colitis outbreaks associated with a rare Escherichia coli serotype[J].Journal of Clinical Microbiology,1983,18(3):512-520.
[27]Nicole T.Perna,Guy Plunkett,Valerie Burland,et al.Genome sequence of enterohaemorrhagic Escherichia coli O157:H7[J].Nature,2001(409): 529-533.
[28]Wick L M,Qi W,Lacher D W,et al.Evolution of genomic content in the stepwise emergence of Escherichia coli O157:H7[J].Bacteriol,2005(187): 1783-1791.
[29]Kensuke Shima,Noriyo Yoshii, Masato Akiba,et al.Comparison of PCR-RFLP and PFGE for determining the clonality of enterohemorrhagic Escherichia coli strains[J].FEMS Microbiol Lett,2006(257): 124-131.
[30]Geraldine A.Willshaw,Henry R.Smith,Thomas Cheasty,et al.Vero cytotoxinproducing Escherichia coli O157 outbreaks in England and Wales,1995: Phenotypic methods and genotypic subtyping[J].Emerg Infect Dis,1997(3): 561-565.
[31]Brian R.Murphy,Stephen S.Whitehead.Immune response to dengue virus and prospects for a vaccine[J].Annual Review of Immunology,2011(29): 587-619.
[32]Richard J.Kuhn,Wei Z,Michael G.Rossmann,et al.Structure of dengue virus:implications for flavivirus organization,maturation,and fusion[J].Cell,2002,108(5): 717-725.
[33]Rushika Perera,Mansoora Khaliq,Richard J,et al.Closing the door on flaviviruses: entry as a target for antiviral drug design[J].Antiviral Research,2008,80(1): 11-22.
[34]Kala Jessie,Mum Yik Fong,Shamala Devi,et al.Localization of dengue virus in naturally infected human tissues by immunohistochemistry and in situ hybridization[J].Journal of Infectious Diseases,2004,189(8): 1411-1418.
[35]Shuenn-Jue L.Wu,Geraldine Grouard-Vogel,Wellington Sun,et al.Human skin Langerhans cells are targets of dengue virus infection[J].Nature Medicine,2000,6(7): 816-820.
[36]Alvaro Molina-Cruz,Lalita Gupta,Jason Richardson,et al.Effect of mosquito midguttrypsin activity on dengue-2 virus infection and dissemination in Aedes aegypti[J].The American Journal of Tropical Medicine and Hygiene,2005,72(5): 631-637.
[37]Salazar M I,Richardson J H,Sanchez-vargas I,et al.Dengue virus type 2:replication and tropisms in orally infected Aedes aegypti mosquitoes[J].BMC Microbiology,2007(7):1-13.
[38]Perry R F J.Yersinia pestis-etiologic agent of plague[J].Clin Microbiol Rev,1997(10): 35-66.
[39]Bertherat E,World Health Organization.Plague around the world,2010-2015[J].Wkly Epidemiol Rec.,2016,91:89-93.
[40]McNally A,Thomson N,Reuter S,et al.Add,stir and reduce: Yersinia spp.as model bacteria for pathogen evolution[J].Nat Rev Microbiol,2016(14): 177-190.
[41]Yujun Cui,Chang Yu,Yanfeng Yan,et al.Historical variations in mutation rate in an epidemic pathogen,Yersinia pestis[J].PNAS,2013(110): 742-754.
[42]Diepold A,Sezgin E,Huseyin M,et al.A dynamic and adaptive network of cytosolic interactions governs protein export by the T3SS injectisome[J].Nature Communications,2017,8:15940.
[43]Smart,C.Five reasons to consider Phytophthora infestans a reemerging pathogen[J].Phytopathology,2015,105(7): 966-981.
[44]Hardham A R.Cell biology of plant-oomycete interactions[J].Cellular Microbiology,2007,9(1): 31-39.
[45]Hohl H R,Suter E.Host-parasite interfaces in a resistant and a susceptible cultivar of Solanum tuberosum inoculated with Phytophthora infestans: leaf tissue[J].Can.j.bot,1976,54(16): 1956-1970.
[46]Baldi P C,Giambartolomei G H.Pathogenesis and pathobiology of zoonotic brucellosis in humans[J].Revue entifique Et Technique,2013,32(1): 117-125.
[47]Godfroid J,Al Dahouk S,Pappas G,et al.A “One Health” surveillance and control of brucellosis in developing countries: moving away from improvisation[J].Comparative Immunology,Microbiology and Infectious Diseases,2013,36(3):241-248.
[48]Strausbaugh L J,Berkelman R L.Human illness associated with use of veterinary vaccines[J].Clinical Infectious Diseases,2003(3):407-414.
[49]Roth F,Zinsstag J,Orkhon D,et al.Human Health Benefits from Livestock Vaccination for Brucellosis: Case Study[J].Bulletin of the World Health Organization,2003,81: 867-876.
[50]Karayiannis P,Hepatitis B virus: virology,molecular biology,life cycle and intrahepatic spread[J].Hepatol Int.2017,11(12):1-9.
[51]Locarnini S A,Roggendorf M .Other Hepadnaviridae[Avihepadnaviridae(DHBV) and Orthohepadnaviridae (WHV)][M].Viral Hepatitis.John Wiley &Sons,Ltd,2013.
[52]Kramvis,Anna.Genotypes and genetic variability of hepatitis B virus[J].Intervirology,2014,57(3-4):141-150.
[53]Feinstone S M,Kapikian A Z,Purcell R H.Transfusion-associated hepatitis not due to viral hepatitis type A or B[J].The New England journal of medicine,1975,292(15):767-770.
[54]Simmonds P,Becher P,Bukh J,et al.ICTV Virus Taxonomy Profile: Flaviviridae[J].Journal of General Virology,2017,98(1):2-3.
[55]Tsukiyama-Kohara K,Tone S,Maruyama I,et al.Activation of the CKI-CDKRb-E2F pathway in full genome hepatitis C virus-expressing cells[J].Journal of Biological Chemistry,2004,279(15):14531-14541.
[56]Wi T,Lahra M M,Ndowa F,et al.Antimicrobial resistance in Neisseria gonorrhoeae: Global surveillance and a call for international collaborative action[J].PLoS Medicine,2017,14(7):e1002344.
[57]Wadsworth C B ,Arnold B J,Abdul S M R,et al.Azithromycin Resistance through Interspecific Acquisition of an Epistasis-Dependent Eラux Pump Component and Transcriptional Regulator in Neisseria gonorrhoeae[J].mBio,2018,9(4):1419-1437.
[58]Giacani L,Lukehart S A.The Endemic Treponematoses[J].Clin Microbiol Rev.2014,27:89-115.
[59]Janier M,Hegyi V,Dupin N,et al.2014 European guideline on the management of syphilis[J].J Eur Acad Dermatology Venereol.2014,28:1581-1593.
[60]Black V,Williams B G,Maseko V,et al.Field evaluation of Standard Diagnostics’Bioline HIV/Syphilis Duo test among female sex workers in Johannesburg,South Africa[J].Sexually Transmitted Infections,2016,92:495-498.